Koers Dawnrays Pharmaceutical (Holdings) Limited
Aandelen
2348
KYG2687M1006
Farmaceutische producten
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,17 HKD | -2,50% | -11,36% | +11,43% |
Omzet 2021 | 1,17 mld. 161 mln. 1,26 mld. 149 mln. | Omzet 2022 | 1,28 mld. 177 mln. 1,38 mld. 164 mln. | Marktkapitalisatie | 1,76 mld. 244 mln. 1,91 mld. 226 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 358 mln. 49,54 mln. 388 mln. 45,87 mln. | Nettowinst (verlies) 2022 | 358 mln. 49,54 mln. 388 mln. 45,87 mln. | EV/omzet 2021 | 1,06 x |
Nettoliquiditeiten 2021 | 807 mln. 112 mln. 873 mln. 103 mln. | Nettoliquiditeiten 2022 | 1,07 mld. 149 mln. 1,16 mld. 138 mln. | EV/omzet 2022 | 0,54 x |
K/w-verhouding 2021 |
5,73
x | K/w-verhouding 2022 |
4,93
x | Werknemers | 1.143 |
Dividendrendement 2021 |
4,79% | Dividendrendement 2022 |
6,63% | Vrij verhandelbaar | 39,99% |
1 dag | -2,50% | ||
1 week | -11,36% | ||
Lopende maand | -0,85% | ||
1 maand | -2,50% | ||
3 maanden | +14,71% | ||
6 maanden | +4,46% | ||
Lopend jaar | +11,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Xian Wu
CEO | Chief Executive Officer | 55 | 16-02-22 |
Yi jun Wu
DFI | Director of Finance/CFO | 59 | 01-12-02 |
Kei Ling Li
CHM | Chairman | 75 | 01-10-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kei Ling Li
CHM | Chairman | 75 | 01-10-02 |
Yung Lai Hung
BRD | Director/Board Member | 79 | 01-10-02 |
Hong Man Leung
BRD | Director/Board Member | 49 | 01-11-05 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 1,17 | -2,50% | 740 000 |
27-03-24 | 1,2 | +2,56% | 388 000 |
26-03-24 | 1,17 | -0,85% | 474 000 |
25-03-24 | 1,18 | -10,61% | 2 790 000 |
22-03-24 | 1,32 | 0,00% | 434 000 |
uitgestelde koers Hong Kong S.E., 28 maart 2024 om 09:08 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+11,43% | 230 mln. | |
+35,76% | 701 mld. | |
+26,24% | 571 mld. | |
+1,10% | 381 mld. | |
+20,74% | 334 mld. | |
+17,04% | 319 mld. | |
+1,09% | 210 mld. | |
+2,59% | 210 mld. | |
-6,01% | 201 mld. | |
-3,24% | 157 mld. |